APA

Berenson J. R., Swift R. A., Ferretti D. & Purner M. B. (20041216). A prospective, open-label safety and efficacy study of combination treatment with melphalan, arsenic trioxide, and ascorbic acid in patients with relapsed or refractory multiple myeloma. : Clinical lymphoma.

Chicago

Berenson James R, Swift Regina A, Ferretti Delina and Purner Matthew B. 20041216. A prospective, open-label safety and efficacy study of combination treatment with melphalan, arsenic trioxide, and ascorbic acid in patients with relapsed or refractory multiple myeloma. : Clinical lymphoma.

Harvard

Berenson J. R., Swift R. A., Ferretti D. and Purner M. B. (20041216). A prospective, open-label safety and efficacy study of combination treatment with melphalan, arsenic trioxide, and ascorbic acid in patients with relapsed or refractory multiple myeloma. : Clinical lymphoma.

MLA

Berenson James R, Swift Regina A, Ferretti Delina and Purner Matthew B. A prospective, open-label safety and efficacy study of combination treatment with melphalan, arsenic trioxide, and ascorbic acid in patients with relapsed or refractory multiple myeloma. : Clinical lymphoma. 20041216.